CAVALLARO, Lucas Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.940
AS - Asia 1.500
EU - Europa 1.041
SA - Sud America 173
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 52
OC - Oceania 1
Totale 4.793
Nazione #
US - Stati Uniti d'America 1.876
SG - Singapore 559
CN - Cina 428
VN - Vietnam 229
DE - Germania 213
SE - Svezia 197
IE - Irlanda 189
BR - Brasile 129
IT - Italia 119
FI - Finlandia 88
HK - Hong Kong 78
ZA - Sudafrica 52
FR - Francia 51
NL - Olanda 41
BD - Bangladesh 39
TR - Turchia 38
CA - Canada 35
GB - Regno Unito 33
IN - India 31
RU - Federazione Russa 23
CI - Costa d'Avorio 21
AR - Argentina 17
BE - Belgio 15
MX - Messico 15
IQ - Iraq 13
PL - Polonia 13
IR - Iran 12
ES - Italia 11
EC - Ecuador 10
PK - Pakistan 10
LT - Lituania 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
TH - Thailandia 7
UZ - Uzbekistan 7
AT - Austria 6
EU - Europa 6
NP - Nepal 5
SA - Arabia Saudita 5
CL - Cile 4
HU - Ungheria 4
JP - Giappone 4
PH - Filippine 4
PT - Portogallo 4
PY - Paraguay 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
GR - Grecia 3
IL - Israele 3
KG - Kirghizistan 3
MA - Marocco 3
RO - Romania 3
AZ - Azerbaigian 2
BB - Barbados 2
CR - Costa Rica 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
KR - Corea 2
LV - Lettonia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SR - Suriname 1
TN - Tunisia 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.747
Città #
Ashburn 321
Chandler 307
Singapore 303
Dublin 176
Munich 164
Santa Clara 155
San Jose 149
Beijing 82
Hong Kong 77
Ho Chi Minh City 74
Boardman 65
Helsinki 65
Nanjing 60
Dearborn 55
Los Angeles 53
Shanghai 53
Johannesburg 48
Dallas 47
Hanoi 47
New York 45
Council Bluffs 35
Princeton 30
Izmir 28
Lauterbourg 27
Frankfurt am Main 25
Ann Arbor 23
Buffalo 22
Parma 22
Abidjan 21
Turku 21
Wilmington 17
Moscow 15
Pune 15
Brussels 14
Hefei 14
San Mateo 14
São Paulo 14
Toronto 14
Nanchang 13
Shenyang 13
Tianjin 13
London 12
Changsha 11
Phoenix 10
Boston 9
Can Tho 9
Haiphong 9
Kunming 9
Milan 9
Montreal 9
Orem 9
Warsaw 9
Jiaxing 8
Jinan 8
Columbus 7
Da Nang 7
Hải Dương 7
Norwalk 7
Bremen 6
Denver 6
Hangzhou 6
Houston 6
Kocaeli 6
Lahore 6
Chengdu 5
Chennai 5
Curitiba 5
Guangzhou 5
Hebei 5
Menlo Park 5
Quito 5
Rome 5
Seattle 5
Tashkent 5
Thái Bình 5
Zanjan 5
Augusta 4
Baghdad 4
Bangkok 4
Brooklyn 4
Cambridge 4
Mexico City 4
Ningbo 4
Nuremberg 4
Olomouc 4
Thái Nguyên 4
Tokyo 4
Andover 3
Atlanta 3
Bishkek 3
Biên Hòa 3
Brno 3
Bình Phước 3
Charlotte 3
Chicago 3
Erbil 3
Frattamaggiore 3
Grafing 3
Kathmandu 3
Long Xuyen 3
Totale 3.084
Nome #
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 296
Changes in surgical behaviors during the CoviD-19 pandemic. The SICE CLOUD19 Study 243
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 206
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 173
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 167
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 165
Does chronic hypercalcemia influence serum pepsinogens levels? 156
Gastro panel® for detection of atrophic gastritis: The “Parma model” 154
Serum pepsinogen II for early assessment of success of H. pylori eradication 150
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 149
NOD2 and Crohn’s Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired 145
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 145
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage 144
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 142
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 140
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 140
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 139
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 139
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 138
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 136
PA.27 GASTRO PANEL® FOR DETECTION OF ATROPHIC GASTRITIS: THE “PARMA MODEL” 135
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 135
The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study 135
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 131
Clinical presentation of 324 patients with hepatocellular carcinoma (HCC) in a single center of North Italy 128
Cancro gastrico e Helicobacter pylori 128
A new curcumin-based one week therapy for eradication of H. pylori infection 122
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD 121
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 121
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 115
La diagnosi sierologica delle gastriti croniche atrofiche 113
Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study 112
null 30
Totale 4.793
Categoria #
all - tutte 16.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022237 0 11 1 44 29 6 12 11 10 15 32 66
2022/2023808 67 99 71 86 56 100 5 64 223 4 31 2
2023/2024279 11 19 5 6 21 68 23 32 10 17 36 31
2024/20251.087 37 39 43 58 126 132 59 63 179 70 92 189
2025/20261.858 231 119 154 209 279 130 149 56 236 175 75 45
2026/202790 45 45 0 0 0 0 0 0 0 0 0 0
Totale 4.793